Recent 8-K filings for LTBR
Highest-materiality recent filing
Lightbridge achieves successful co-extrusion of nuclear fuel coupon sample at Idaho National Laboratory
- Co-extrusion demonstration produced an 8-foot rod of uranium-zirconium alloy encased in nuclear-grade zirconium cladding.
- Milestone under Lightbridge's Strategic Partnership Project Agreement with Battelle Energy Alliance (BEA) for Idaho National Laboratory.
-
Lightbridge Corp. announces 2026 annual meeting voting results; all proposals passed
All six director nominees elected with ~10.5M votes each; broker non-votes of 11.1M.
-
Lightbridge Q1 2026 net loss widens to $6.3M; cash balance rises to $215.7M
Net loss $6.3M in Q1 2026, up from $4.8M in Q1 2025; R&D expenses doubled to $3.3M.
-
Lightbridge FY2025 net loss widens to $19.6M; working capital jumps to $201.7M
Net loss of $19.6M vs $11.8M in FY2024; R&D expenses doubled to $9.2M on fuel development activities.
-
Lightbridge Q3 net loss widens to $4.1M; cash rises to $153.3M on ATM raises
Q3 net loss of $4.1M vs $2.7M a year ago; nine-month net loss $12.4M vs $7.9M.
-
Lightbridge files prospectus supplement for $75M at-the-market equity offering
Filed prospectus supplement on Sept 26, 2025 to sell up to $75M of common stock via ATM program with Jefferies.
-
Lightbridge grants 640K+ performance-based restricted shares to executives, CEO gets 290,830 shares
Board approved RSA Grants on Aug 28, 2025 to CEO Seth Grae (290,830 shares), EVP Andrey Mushakov (181,389), and CFO Larry Goldman (167,809).
-
Lightbridge Q2 net loss $3.5M; cash $97.9M after $60.9M ATM raise; INL milestones
Net loss of $3.5M in Q2 2025 vs $2.4M in Q2 2024; six-month net loss $8.3M vs $5.2M.
-
Lightbridge enters $75M ATM equity offering with Jefferies LLC
Up to $75M of common stock may be sold from time to time under an at-the-market offering.
-
Lightbridge Q1 net loss widens to $4.8M; cash rises to $56.9M on ATM issuance
Net loss of $4.8M for Q1 2025 compared to $2.8M in Q1 2024, driven by higher R&D and G&A costs.
-
Lightbridge shareholders approve 4x increase in authorized shares, expansion of incentive plan
Authorized common shares increased from 25M to 100M; voted 27.8M for, 7.6M against.
-
Lightbridge amends Idaho National Lab agreement; increases potential funding by $600K
Modification No. 4 raises potential payable amount to Battelle by ~$600K, total estimated cost to $2.6M under the umbrella SPPA.
-
Lightbridge issues Series X Preferred Stock to director to secure vote on authorized share increase
One share of Series X Preferred Stock issued to Audit Committee chair Jesse Funches for $100 on Feb 27, 2025.
-
Lightbridge FY2024 net loss $11.8M, cash $40M; R&D spend doubles, fuel milestones achieved
Net loss $11.8M (2023: $7.9M); working capital $39.9M; cash $40.0M, up $11.4M from ATM issuance.
-
Co-extrusion demonstration produced an 8-foot rod of uranium-zirconium alloy encased in nuclear-grade zirconium cladding.
-
Non-binding MOU signed Jan 22, 2025, with Oklo Inc. to study co-locating Lightbridge's fuel fabrication facility at Oklo's proposed facility.
-
Lightbridge increases funding commitment to Battelle for nuclear fuel R&D by $1.6M
Modification No. 3 raises potential payments to Battelle by ~$1.6M, total est. cost now $5.4M.
-
Lightbridge updates ATM equity offering capacity to $45.2M remaining
As of Nov 22, 2024, the company sold $12.4M of the $12.595M under prior August 2024 prospectus supplement.
-
Lightbridge posts Q3 net loss of $2.7M; R&D spend jumps to $1.3M
Net loss of $2.7M in Q3 2024 vs $1.8M in Q3 2023.
-
Modification No. 3 raises Lightbridge's reimbursable cap to Battelle by ~$294,416; total estimated cost now $2,003,048 under Umbrella SPPA.
-
Lightbridge files new prospectus supplement for ongoing ATM equity offering
ATM sales agreement originally dated May 28, 2019, was amended most recently on May 8, 2024.
-
Lightbridge Q2 2024 net loss widens to $2.4M; cash burn increases on R&D spend
Net loss of $2.4M for Q2 2024 vs. $1.7M in Q2 2023; revenue not reported (pre-revenue developer).
-
Lightbridge files prospectus supplement for ATM equity offering program
Filed prospectus supplement dated July 19, 2024 under effective Form S-3 registration statement (File No. 333-278388).
-
Lightbridge Q1 net loss widens to $2.8M; cash burn increases on R&D ramp
Net loss of $2.8M for Q1 2024 vs $2.0M in Q1 2023, driven by higher R&D and G&A costs.
-
Lightbridge shareholders approve increase in equity plan shares to 2.5M at 2024 annual meeting
All six director nominees elected: Grae, Chakraborty, Funches, Goodman, Magraw, Tobin.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.75 · Median 0.55 · Most common event other_material